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Abstract
Background: Frailty is a dynamic age-related condition of increased vulnerability characterized by declines across multiple
physiologic systems and associated with an increased risk of death. We compared the predictive accuracy for one-month
and one-year all-cause mortality of four frailty instruments in a large population of hospitalized older patients in a
prospective multicentre cohort study.
Methods and Findings: On 2033 hospitalized patients aged $65 years from twenty Italian geriatric units, we calculated the
frailty indexes derived from the Study of Osteoporotic Fractures (FI-SOF), based on the cumulative deficits model (FI-CD),
based on a comprehensive geriatric assessment (FI-CGA), and the Multidimensional Prognostic Index (MPI). The overall
mortality rates were 8.6% after one-month and 24.9% after one-year follow-up. All frailty instruments were significantly
associated with one-month and one-year all-cause mortality. The areas under the receiver operating characteristic (ROC)
curves estimated from age- and sex-adjusted logistic regression models, accounting for clustering due to centre effect,
showed that the MPI had a significant higher discriminatory accuracy than FI-SOF, FI-CD, and FI-CGA after one month (areas
under the ROC curves: FI-SOF = 0.685 vs. FI-CD= 0.738 vs. FI-CGA= 0.724 vs. MPI = 0.765, p,0.0001) and one year of follow-
up (areas under the ROC curves: FI-SOF = 0.694 vs. FI-CD= 0.729 vs. FI-CGA= 0.727 vs. MPI = 0.750, p,0.0001). The MPI
showed a significant higher discriminatory power for predicting one-year mortality also in hospitalized older patients
without functional limitations, without cognitive impairment, malnourished, with increased comorbidity, and with a high
number of drugs.
Conclusions: All frailty instruments were significantly associated with short- and long-term all-cause mortality, but MPI
demonstrated a significant higher predictive power than other frailty instruments in hospitalized older patients.
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Introduction
In the last years, different conceptual definitions of frailty have
been reported, i.e., phenotypic [1], accumulation of deficits [2],
and multiple domain aggregate or multidimensional [3]. Mainly
based on this last model, an integral conceptual working definition,
taking into account essential components of existing conceptual
definitions [4,5], indicates frailty as a dynamic age-related
condition of increased vulnerability characterized by declines
across multiple physiologic systems and associated with an
increased risk of negative outcomes, i.e., institutionalization and
death [6]. Recently, frailty was demonstrated to be the most
common condition leading to death in older people [7], suggesting
that in clinical practice it is crucial to identify frailty in the older
patient. Several instruments based on different conceptual
approaches and validated in different settings and populations
have been developed to detect frailty, and their predictive validity
for mortality has also been established [8]. The different
instruments, based on different conceptualization of frailty,
however, capture different groups of older patients [9]. This is
particularly problematic evaluating hospitalized older patients
because prognostic information would be extremely useful in
setting standard guidelines for care management, and follow-up
after hospital discharge, and test their effectiveness [10].
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In the present study, we compared four instruments, corre-
sponding to the updated most widely accepted conceptual
definitions of frailty [1–3], in the prediction of all-cause mortality
of hospitalized older patients. For the phenotypic model, we used
the frailty index derived from the Study of Osteoporotic Fractures
(FI-SOF) [11,12], which compared to the original frailty index as
described by Fried and colleagues in the Cardiovascular Health
Study (FI-CHS) is more easily implemented in a clinical setting
[1,13]. For the frailty index based on the cumulative deficits (FI-
CD), we used the model described by Kulminski and colleagues
[14]. For the multidimensional model, we used the frailty index
based on a Comprehensive Geriatric Assessment (CGA) (FI-CGA)
[15,16] and the CGA-based Multidimensional Prognostic Index
(MPI) [17]. CGA is defined as a multidimensional, interdisciplin-
ary diagnostic process to determine the medical, psychological and
functional capabilities of frail older people in order to develop a
co-ordinated and integrated plan for treatment and long-term
follow up [18,19]. In particular, the FI-CGA explored ten domains
(cognitive status, mood and motivation, communication, mobility,
balance, bowel function, bladder function, functional status,
nutrition, and social resources) and was validated on a randomized
clinical trial [15] and the Canadian Study of Health and Aging, a
large population-based study [16]. The MPI is a validated CGA-
based algorithm that was developed on hospitalized older patients
integrating data from eight domains including information on
functional, cognitive, nutritional, comorbidities, drug use, risk of
developing pressure sores, and co-habitation status [17].
Although validated on different settings (population-based
studies, randomized clinical trial, or hospital-based settings), the
criteria used to select the frailty instruments were their previous
validation as prognostic tools for all-cause mortality in older
people [11–17] and their feasibility in clinical practice [8]. The
aim of the present study was to compare the accuracy of the four
above-reported frailty instruments in predicting one-month and
one-year all-cause mortality in hospitalized older patients.
Materials and Methods
Study population
The present was a prospective cohort study conducted
according to the Declaration of Helsinki, the guidelines for Good
Clinical Practice, and the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) guidelines
(available at URL http://www.strobe-statement.org/). This study
was approved by Institutional Review Boards (IRBs) of the twenty
Italian Geriatric Wards involved and in particular by the IRBs of
San Giovanni Rotondo (Foggia), Naples, Rome, Florence, and
Turin. Written informed consent for research was obtained from
each patient or from relatives or a legal guardian. Patients aged 65
years and older admitted from February 1 to March 31, 2008 due
to acute disease or relapse of a chronic disease were screened for
eligibility at 20 Italian geriatric units, homogeneously distributed
on the Italian territory (eight from Northern Italy, four from
Central Italy, and eight from Southern Italy). Inclusion criteria
were: 1) age $65 years; 2) ability to provide an informed consent
or availability of a proxy for informed consent; 3) complete data
collection to carry out the four indexes during hospitalization. In
particular, the information to calculate the four frailty indexes
were collected in a single session during hospitalization, and the
data to calculate activities of daily living (ADL) [20] and
instrumental ADL (IADL) [21] were collected one time alone for
both the FI-CGA and the MPI. The main and secondary
diagnoses at discharge from the hospital, coded according to the
Italian translation of the International Classification of Diseases,
9th revision, Clinical Modification (ICD-9-CM) (available at URL
http://icd9cm.chrisendres.com/icd9cm/) were also recorded in
all patients. Vital status up to April 1, 2009 was assessed by directly
contacting the participants or consulting the Registry Offices of the
cities where the patients were residents at the time of hospital
admission.
Frailty index derived from the Study of Osteoporotic
Fractures (FI-SOF)
Some conceptual definitions of frailty are based on physical
diminution in older people [1,22]. The FI-CHS developed by
Fried and colleagues is an operational definition of frailty in older
subjects based on the presence of any three of the following five
characteristics: shrinking, weakness, poor endurance, slowness,
and low physical activity [1], so suggesting a phenotypic model of
frailty. In the present study, for this phenotypic model, we selected
the FI-SOF recently proposed by Ensrud and colleagues as a
simpler index that might be more suitable for assessing frailty in a
clinical practice setting [11,12]. The FI-SOF was calculated on the
basis of the following three items: a) unintentional weight loss, i.e.,
not due to diet or exercise, of more than 4.5 kg during the last
year; b) inability to rise from a chair five times without the use of
arms; c) low energy level as evaluated by the answer to the
question ‘‘did you feel like you could not get going?’’; those who
reported that this feeling had occurred three days or more in the
previous week were considered as demonstrating low energy level.
Frailty status was defined as robust (0 components), prefrail (1
component), and frail (2 or 3 components) and expressed in three
grades from grade 1 to grade 3 of frailty.
Frailty index based on cumulative deficits (FI-CD)
Another conceptual approach to frailty suggests that an index
based on health/well-being disorders (e.g., signs, symptoms,
impairments, abnormal laboratory tests, diseases, etc.) accumulat-
ed by individuals during their life course can be considered as
indicators of physiological frailty [2,22]. The level of frailty can
then be described by a composite measure of such disorders (called
deficits), which can be determined for each individual as the
fraction of deficits among a selected list of items that measure
various aspects of health/well-being status. For this model of
frailty, we selected the FI-CD [12] calculated considering a set of
32 deficits: difficulty with eating, dressing, walk around, getting in/
out bed, getting bath, toileting, using telephone, going out,
shopping, cooking, light house work, taking medicine, managing
money, arthritis, Parkinson’s disease, glaucoma, diabetes, stomach
problems, history of heart attack, hypertension, history of stroke,
flu, broken hip, broken bones, trouble with bladder/bowels,
dementia, self-rated health, as well as problems with vision,
hearing, ear, teeth, and feet. To calculate the index it is necessary
to count the number of such deficits divided by the total number of
all potential deficits considered for a given person. This index was
expressed as a continuous variable.
Frailty index based on a Comprehensive Geriatric
Assessment (FI-CGA)
Some researchers have criticized the definitions of phenotypic
frailty and a model based on cumulative deficits [5,22,23],
suggesting that an integral conceptual approach is needed to
identify and measure frailty in clinical practice, an approach in
which the focus is not exclusively on the physical domains, but
which also incorporates the evaluation of psychological and social
domains, and is thus based on the integral functioning of the
individual [4,5]. For this multidimensional approach to frailty, we
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selected the FI-CGA [15,16] calculated by counting the number of
impairments identified in ten domains: 1) cognitive status; 2) mood
and motivation, rated separately and then combined so that the
highest level of specificity was scored for the domain; 3)
communication, i.e. vision, hearing and speech; 4) mobility and
5) balance (each of the latter two scored at the highest level of
independence also with the use of mobility or balance aids); 6)
bowel function; 7) bladder function; 8) ADL [20], and IADL) [21],
rated as no impairment = no problem, IADL impairment =mild
problem, ADL impairment =major problem; 9) nutrition, and 10)
social resources, scored as a problem if there was need for
additional help. Problems in each domain were scored as 0= no
problem, 1=minor problem, or 2 =major problem. The FI-CGA
was expressed in three grades of frailty, i.e. FI-CGA 1=mild, FI-
CGA 2=moderate and FI-CGA 3= severe; the cut-off for mild,
moderate and severe frailty were respectively 0–7, 7–13, and .13.
Multidimensional Prognostic Index (MPI)
Finally, we also selected for the multidimensional and CGA-
based model of frailty the MPI [17] calculated from information
on eight domains including: 1) functional status assessed by the
ADL [20] and 2) the IADL [21] scales; 3) cognitive status assessed
by the Short Portable Mental Status Questionnaire (SPMSQ) [24];
4) comorbidity as assessed by the Cumulative Illness Rating Scale
(CIRS) [25]; 5) nutritional status according to the Mini Nutritional
Assessment (MNA) [26]; 6) the risk of developing pressure sores
assessed by the Exton Smith Scale (ESS) [27]; 7) the number of
drugs taken by patients at admission and 8) co-habitation status,
i.e. alone, in family or in institution. For each domain a tripartite
hierarchy was used, i.e. 0 = no problems, 0.5 =minor problems,
and 1=major problems. The final MPI was expressed as three
grades of risk of all-cause mortality: MPI-1 low risk (MPI value
#0.33), MPI-2 moderate risk (MPI value between 0.34 and 0.66)
and MPI-3 severe risk of all-cause mortality (MPI value .0.66).
Table 1 summarized the methodological constructs of the four
different frailty instruments.
Statistical analysis
Patients’ baseline characteristics were reported as mean 6
standard deviation (SD) or frequencies and percentages for
continuous and categorical variables, respectively. Baseline
comparisons between men and women were assessed using
generalized linear mixed-effects models accounting for clustering
due to centre effect. Rank analysis were performed when skewness
was present in continuous variables’ distribution. Incidence rates
(IR) for 100 person-month and 100 person-year over one-month
and one-year of follow-up were also reported. Poisson regression
models, accounting for clustering due to centre effect, were
assessed to test differences in IR between men and women.
Hazard ratios (HR) and 95% confidence intervals (95% CI)
estimated from univariate proportional hazards regression models,
accounting for clustering due to centre effect, were also shown.
The discriminatory power, for one-month and one-year mortality,
was assessed by estimating the area under the receiver operating
characteristic (ROC) curves for crude and age- and sex-adjusted
predictive models, accounting for clustering due to centre effect.
Table 1. Summary of the methodological constructs of the four frailty indexes compared.
Frailty index Evaluated parameters Frailty determination Conceptual approach
FI-SOF (11, 12) 3 items: 1) unintentional weight loss; 2) inability to rise from a
chair five times without the use of arms; 3) low energy level
Robust: 0 component; prefrail: 1 component;
frail 2 or 3 components. Only grading available
Phenotypic
FI-CD (14) 32 items: difficulty with eating, dressing, walk around, getting in/
out bed, getting bath, toileting, using telephone, going out,
shopping, cooking, light house work, taking medicine, managing
money, arthritis, Parkinson’s disease, glaucoma, diabetes, stomach
problems, history of heart attack, hypertension, history of stroke,
flu, broken hip, broken bones, trouble with bladder/bowels,
dementia, self-rated health, as well as problems with vision,
hearing, ear, teeth, and feet
The sum of the presence of deficits
divided by the total number of all
potential deficits. No grading available
Accumulation of deficits
FI-CGA (13) 10 domains: 1) cognitive status; 2) mood and motivation; 3)
communication; 4) mobility; 5) balance; 6) bowel function; 7)
bladder function; 8) basal ADL and IADL); 9) nutrition; 10)
social resources
Problems in each domain were scored 0 (no
problem), 1 (minor problem) and 2 (major
problem). The sum determine the index. The
cut-off for mild, moderate and severe frailty
were respectively 0–7, 7–13 and .13
Multidimensional
MPI (14) 8 domains: 1) basal ADL; 2) IADL; 3) cognitive (SPMSQ); 4)
comorbidity (CIRS); 5) nutrition (MNA); 6) risk of developing
pressure sores (ESS); 7) the number of drugs taken by
patients at admission; 8) co-habitation status
For each domain a tripartite hierarchy was
used: 0=no problems, 0.5=minor problems
and 1=major problems. The sum was divided
by the total number of the domains. The final
MPI was expressed as three grades of risk of
all-cause mortality: low risk (value #0.33),
moderate risk (value between 0.34 and 0.66)
and severe risk (value .0.66)
Multidimensional
FI-SOF: Frailty Index derived from the Study of Osteoporotic Fractures;
FI-CD: Frailty Index based on cumulative deficits;
FI-CGA: Frailty Index based on a Comprehensive Geriatric Assessment;
ADL: activities of daily living;
IADL: instrumental activities of daily living;
SPMSQ: Short Portable Mental Status Questionnaire;
CIRS: Cumulative Illness Rating Scale;
MNA: Mini Nutritional Assessment;
ESS: Exton-Smith Scale;
MPI: Multidimensional Prognostic Index.
doi:10.1371/journal.pone.0029090.t001
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Comparisons between the areas under the ROC curves were
carried out using DeLong’s test [28] both evaluating all patients
and all possible subgroups defined by taking into account all
clinical domains used to calculate the frailty indexes. Subgroups
where some of these indexes showed a significant more or less
discriminatory power than the others were reported. A p
value,0.05 was considered for statistical significance. All analyses
were performed using SAS Release 9.1 (SAS Institute, Cary, NC,
USA).
Results
Characteristics of the study population
During the enrolment period, 2,322 consecutive patients were
admitted to the 20 geriatric units and eligible for inclusion in the
study. One hundred and eleven subjects were excluded because
they were younger than 65 years, and 76 patients were excluded
because data collection was not completed. Moreover, in 102
patients information on vital status after one year of follow-up was
Table 2. Baseline characteristics of hospitalized older patients according to gender.
All Men Women p-value**
Patients (n, %) { 2033 (100) 874 (43.0) 1159 (57.0) ----
Age (years) * 79.867.8 78.767.5 80.668.0 ,0.0001
FI-SOF - Grade 1 (n,%) { 686 (33.7) 364 (41.6) 322 (27.8) ,0.0001
FI-SOF - Grade 2 (n,%) { 804 (39.5) 313 (35.8) 491 (42.4)
FI-SOF - Grade 3 (n,%) { 543 (26.7) 197 (22.5) 346 (29.9)
FI-CD * 10.366.2 9.566.0 10.966.3 ,0.0001
FI-CGA - Grade 1 (n,%) { 1417 (69.7) 671 (76.8) 746 (64.4) ,0.0001
FI-CGA - Grade 2 (n,%) { 593 (29.2) 191 (21.9) 402 (34.7)
FI-CGA - Grade 3 (n,%) { 23 (1.1) 12 (1.4) 11 (0.9)
MPI - Grade 1 (n,%) { 851 (41.9) 429 (49.1) 422 (36.4) ,0.0001
MPI - Grade 2 (n,%) { 743 (36.5) 300 (34.3) 443 (38.2)
MPI - Grade 3 (n,%) { 439 (21.6) 145 (16.6) 294 (25.4)
ADL score * 3.862.5 4.262.4 3.562.5 ,0.0001
IADL score * 3.763.1 3.963.0 3.663.2 0.1028
SPMSQ score * 2.863.0 2.463.0 3.163.1 ,0.0001
Exton Smith score * 15.663.7 16.363.6 15.163.6 ,0.0001
CIRS-CI score * 3.361.9 3.362.0 3.361.9 0.7495
MNA score * 20.565.8 21.465.7 19.965.8 ,0.0001
Number of drugs * 4.562.7 4.462.8 4.662.7 0.1656
Main Diagnoses
Diseases of the circulatory system (n,%){{ 505 (24.8) 228 (26.1) 277 (23.9) 0.6415
Diseases of the respiratory system (n,%) 329 (16.2) 169 (19.3) 160 (13.8) 0.2336
Cerebrovascular disease (n,%) 298 (14.7) 136 (15.6) 162 (14) 0.8227
Disease of the digestive system (n,%) 209 (10.3) 83 (9.5) 126 (10.9) 0.9258
Disease of the nervous system (n,%) 208 (10.2) 78 (8.9) 130 (11.2) 0.7701
Secondary diagnoses
Essential hypertension (n, %) 553 (27.2) 206 (23.6) 347 (29.9) 0.1324
Diabetes mellitus (n, %) 387 (19) 154 (17.6) 233 (20.1) 0.6311
Cardiac dysrhythmias (n, %) 382 (18.8) 153 (17.5) 229 (19.8) 0.6676
Chronic bronchitis (n, %) 335 (16.5) 182 (20.8) 153 (13.2) 0.0918
Chronic ischemic heart disease (n,%) 278 (13.7) 151 (17.3) 127 (10.9) 0.1791
Cerebral atherosclerosis (n,%) 265 (13) 111 (12.7) 154 (13.3) 0.9667
Hypertensive heart disease (n, %) 225 (11.1) 86 (9.8) 139 (12) 0.7707
Mortality - 1 month (events/pm, %ir) 165/1927 (8.6) 77/828 (9.3) 88/1099 (8.0) 0.7328
Mortality - 1 year (events/py, %ir) 430/1725 (24.9) 201/732 (27.4) 229/993 (23.0) 0.7617
*continuous variables;
{categorical variables; pm=person-month; py = person-years; ir = incidence rate.
**p-values obtained fitting generalized linear mixed-effects models, using variable rank values, accounting for clustering due to centre effect.
{{Excluding cerebrovascular disease.
FI-SOF: Frailty Index derived from the Study of Osteoporotic Fractures; FI-CD: Frailty Index based on cumulative deficits; FI-CGA: Frailty Index based on a Comprehensive
Geriatric Assessment; ADL: activities of daily living; IADL: instrumental activities of daily living; SPMSQ: Short Portable Mental Status Questionnaire; CIRS: Cumulative
Illness Rating Scale; MNA: Mini Nutritional Assessment;
ESS: Exton-Smith Scale; MPI: Multidimensional Prognostic Index.
doi:10.1371/journal.pone.0029090.t002
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not available. Thus, the final analysis was performed in 2,033
patients, 874 men (43%) and 1159 women (57%). As shown in
Table 2, the mean age was 79.867.8 years. As expected, women
were significantly older (p,0.0001) and demonstrated an higher
level of frailty than men. No significantly differences were observed
between men and women for the main and secondary diagnoses at
discharge. The overall mortality rates were 8.6% at one month
and 24.9% at one year of follow-up, without significant differences
between men and women.
Comparison among different frailty instruments
As shown in Table 3, all the frailty instruments were
significantly associated with one-month and one-year all-cause
mortality. Table 4 shows the areas under the ROC curves of the
four frailty instruments investigated for one-month and one-year
mortality from both crude and age- and sex-adjusted logistic
regression models, accounting for clustering due to centre effect
(Figure 1). The MPI demonstrated a significant higher discrim-
inatory accuracy than FI-SOF, FI-CD, and FI-CGA after one
month (areas under the ROC curves: SOF=0.685 vs FI-
CD=0.738 vs FI-CGA=0.724 vs MPI= 0.765, p,0.0001) and
one year of follow-up (areas under the ROC curves: FI-
SOF=0.694 vs. FI-CD=0.729 vs. FI-CGA=0.727 vs.
MPI= 0.750, p,0.0001). No differences in accuracy were
observed between the FI-CD and the FI-CGA, while the FI-
SOF demonstrated a lower accuracy than either FI-CD and FI-
CGA both after one-month and one-year of follow-up (Table 4).
Multidimensional domain analysis in different frailty
instruments
Table 5 showed subgroups of hospitalized older patients where
the different frailty instruments demonstrated a significant
different predictive discriminatory power for one-year all-cause
mortality according to the multidimensional domain analysis. The
MPI showed a significant higher discriminatory power for
prediction of one-year mortality than the other indexes in patients
without functional limitations (ADL=5–6 and IADL=6–8) or
cognitive impairment (SPMSQ=0–3). The MPI had also a
significant higher prognostic accuracy than other frailty instru-
ments in hospitalized patients with malnutrition (MNA,17),
higher level of comorbidity (CIRS$3), and in those who were
taking a higher number of drugs ($7) (Table 5).
Discussion
In the present study, we demonstrated that the MPI was more
effective than the other frailty instruments in predicting short- and
long-term all-cause mortality risk in hospitalized older patients
admitted to geriatric units. Furthermore, the MPI showed a
significant higher discriminatory power for prediction of one-year
all-cause mortality than the other frailty indexes in some
subgroups of hospitalized older patients, i.e., those without
functional limitations, those without cognitive impairment, those
malnourished, with higher level of comorbidity, and those who
were taking an high number of drugs.
Cumulative clinical evidence suggested that the MPI has
demonstrated its validity and accuracy in predicting all-causes
mortality in several previous studies carried out in hospitalized
older patients with acute diseases or relapse of a chronic disease
such as gastrointestinal bleeding [29], pneumonia [30], heart
failure [31], chronic kidney disease [32], liver cirrhosis [33], and
dementia [34]. In the present cohort, women demonstrated a
significantly higher level of frailty than men, as detected by all the
four prognostic tools investigated. On the other hand, male gender
was associated with an increased one-year all-cause mortality,
although not significantly, compared to female gender. These
findings confirmed our previous data [17,35] and are in agreement
also with other studies from American [14], Canadian [36], and
Chinese older populations [37], which reported that the gender
difference in life expectancy was not entirely due to differences in
impairment, because men with the same chronological age and
biological impairments (e.g., frailty index) had a higher risk of
death compared with that of women.
The present findings showed further evidence that a multiple-
domain based instrument of frailty, such as the MPI, may be more
effective in predicting short- and long-term all-cause mortality in
hospitalized older patients than other instruments based on
different frailty models, i.e., physical diminution in older persons
(FI-SOF) [11,12] or a deficit accumulation approach (FI-AD) [14].
The present findings also showed that the MPI had higher
predictive discriminatory power than a CGA-based tool (FI-CGA)
[15,16]. However, this last frailty index was calculated as a count
of the impairments identified with the CGA [13], while the MPI
was mainly based on standardized assessment instruments widely
employed in geriatric practice, that comprehensively explored
different domains (ADL, IADL, SPMSQ, CIRS, MNA, and ESS),
so partly explaining the differences of these two tools in predicting
all-cause mortality in this population of hospitalized older patients.
A captivating aspect of the MPI is that it comprises not only a
Table 3. Risk of one-month and one-year all-cause mortality
according to the four frailty instruments in hospitalized older
patients.
Follow-up Frailty index HR 95% CI p-value**
FI-SOF-1 1.00
FI-SOF-2 1.87 1.27–2.76 0.0016
FI-SOF-3 2.42 1.16–5.04 0.0184
FI-CD* 1.13 1.10–1.16 ,0.0001
FI-CGA-1 1.00
1-month follow-up FI-CGA-2 2.92 1.84–4.64 ,0.0001
FI-CGA-3 4.54 1.68–12.24 0.0028
MPI-1 1.00
MPI-2 2.05 1.40–3.00 0.0002
MPI-3 7.70 5.73–10.34 ,0.0001
FI-SOF-1 1.00
FI-SOF-2 1.67 1.29–2.17 ,0.0001
FI-SOF-3 2.45 1.44–4.18 ,0.001
FI-CD* 1.11 1.09–1.13 ,0.0001
FI-CGA-1 1.00
1-year follow-up FI-CGA-2 2.93 2.25–3.83 ,0.0001
FI-CGA-3 4.18 2.10–8.34 ,0.0001
MPI-1 1.00
MPI-2 2.00 1.64–2.45 ,0.0001
MPI-3 5.70 4.49–7.22 ,0.0001
*continuous variables.
**p-values obtained fitting univariate proportional hazard regression models,
accounting for clustering due to centre effect.
HR: hazard ratio; CI: confidence intervals; FI-SOF: Frailty Index derived from the
Study of Osteoporotic Fractures; FI-CD: Frailty Index based on cumulative
deficits; FI-CGA: Frailty Index based on a Comprehensive Geriatric Assessment;
MPI: Multidimensional Prognostic Index.
doi:10.1371/journal.pone.0029090.t003
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grading system but a continuous one. This permits to perform a
more fine analysis in settings where it may be necessary to verify not
only the macroscopic change in mortality but also different risks at
different times. This is possible because the MPI integrates different
domains that could change over time reflecting the current health
status in older people. The integrated and multidimensional
conceptualization of frailty clearly presents advantages over the
other constructs in the recognition of level of frailty in hospitalized
older patients considering short- and long-term all-cause mortality
as the primary outcome. A holistic and dynamic model of frailty
may be central in the management and care of these patients [5]. In
fact, in the present study, the worst performance was achieved by
the FI-SOF [1,11–13], that included only physical components and
not also psychological, cognitive, and social factors.
A very recent systematic review evaluated clinimetric properties
and searched for the best available frailty instrument that can be
used as an evaluative outcome measure in clinical practice and
that may be useful in observational and experimental studies [8].
Based on recent studies [3,5,15], a list of eight frailty risk factors
that are mentioned to be of great importance to the concept of
frailty were identified [8], including in the physical dimension:
nutritional status, physical activity, mobility, strength and energy,
in the psychological dimension: cognition and mood, and in the
social dimension: lack of social contacts and social support. On this
basis, at least twenty frailty instruments have been described [8],
and all these frailty instruments are multidimensional in nature,
and mostly based on a standardized CGA [8]. However, the
overall results of the assessment by using these frailty instruments,
Table 4. Comparison of the areas under the receiver operating characteristic (ROC) curves of the four frailty instruments
compared.*
Frailty index AUC SE 95% CI Contrast p-value
Follow-up Crude/Adjusted Models 1 vs 2 1 vs 3 1 vs 4
1.MPI 0.7486 0.0209 0.71–0.79
Overall 2. FI-SOF 0.5918 0.0208 0.55–0.63 ,0.0001 ,0.0001 ,0.0001
3.FI-CD 0.7094 0.0208 0.67–0.75
4.FI-CGA 0.6924 0.0218 0.65–0.73
1.MPI 0.7396 0.0332 0.67–0.80
Male 2. FI-SOF 0.6163 0.0313 0.55–0.67 0.0002 0.0017 0.0094
Unadjusted 3.FI-CD 0.7013 0.0333 0.64–0.77
4.FI-CGA 0.6923 0.0340 0.62–0.76
1 month 1.MPI 0.7636 0.0260 0.71–0.81
Female 2. FI-SOF 0.5749 0.0279 0.52–0.63 ,0.0001 0.0051 ,0.0001
3.FI-CD 0.7216 0.0259 0.67–0.77
4.FI-CGA 0.6994 0.0282 0.64–0.76
1.MPI 0.7655 0.0203 0.72–0.80
Age- and sex- Overall 2. FI-SOF 0.6854 0.0221 0.64–0.73 ,0.0001 0.0005 ,0.0001
adjusted 3.FI-CD 0.7383 0.0204 0.69–0.78
4.FI-CGA 0.7240 0.0215 0.68–0.77
1.MPI 0.7231 0.0141 0.69–0.75
Overall 2. FI-SOF 0.6034 0.0142 0.57–0.63 ,0.0001 ,0.0001 ,0.0001
3.FI-CD 0.6934 0.0143 0.66–0.72
4.FI-CGA 0.6890 0.0145 0.66–0.72
Unadjusted 1.MPI 0.7164 0.0213 0.67–0.76
1 year Male 2. FI-SOF 0.6196 0.0210 0.58–0.66 ,0.0001 0.0010 0.0048
3.FI-CD 0.6836 0.0221 0.64–0.73
4.FI-CGA 0.6855 0.0219 0.64–0.73
1.MPI 0.7416 0.0184 0.70–0.78
Female 2. FI-SOF 0.5974 0.0193 0.56–0.63 ,0.0001 0.0005 0.0003
3.FI-CD 0.7081 0.0184 0.67–0.74
4.FI-CGA 0.7042 0.0189 0.67–0.74
1.MPI 0.7507 0.0135 0.72–0.78
Age- and sex- Overall 2. FI-SOF 0.6948 0.0142 0.67–0.72 ,0.0001 ,0.0001 ,0.0001
adjusted 3.FI-CD 0.7297 0.0138 0.70–0.76
4.FI-CGA 0.7278 0.0139 0.70–0.75
AUC: areas under curve; SE: standard error; CI: confidence interval; MPI: Multidimensional Prognostic Index; FI-SOF: Frailty Index derived from the Study of Osteoporotic
Fractures; FI-CD: Frailty Index based on cumulative deficits; FI-CGA: Frailty Index based on a Comprehensive Geriatric Assessment.
*AUCs were assessed by crude and adjusted logistic regression models, accounting for clustering due to centre effect.
doi:10.1371/journal.pone.0029090.t004
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Figure 1. Comparisons among different frailty instruments on one-month and one-year all-cause mortality in hospitalized older
patients. Panel A Receiver operating characteristic (ROC) curve comparisons among Multidimensional Prognostic Index (MPI), Frailty Index derived
from the Study of Osteoporotic Fractures (FI-SOF), Frailty Index based on cumulative deficits (FI-CD), and Frailty Index based on a Comprehensive
Geriatric Assessment (FI-CGA) scores on one-month all-cause mortality in hospitalized older patients. Panel B ROC curve comparisons among MPI, FI-
SOF, FI-CD, and FI-CGA scores on one-year all-cause mortality in hospitalized older patients.
doi:10.1371/journal.pone.0029090.g001
Table 5. Subgroups of hospitalized older patients where different frailty indexes showed a significant different predictive
discriminatory power for one-year all-cause mortality.*
Frailty index AUC SE 95% Contrast p-value
1 vs 2 1 vs 3 1 vs 4
1 – MPI 0.7086 0.0199 0.67–0.75
ADL 6-5 2 – FI-SOF 0.6553 0.0210 0.61–0.70 0.0007 0.0004 0.0015
(N=714) 3 - FI-CD 0.6581 0.0209 0.62–0.70
4 - FI-CGA 0.6667 0.0208 0.63–0.71
1 – MPI 0.7277 0.0169 0.69–0.76
IADL 8-6 2 – FI-SOF 0.6569 0.0181 0.62–0.69 ,0.0001 ,0.0001 0.0003
(N=1038) 3 - FI-CD 0.6820 0.0176 0.65–0.72
4 - FI-CGA 0.6897 0.0178 0.65–0.72
1 – MPI 0.7490 0.0170 0.71–0.78
SPMSQ 0-3 2 – FI-SOF 0.7012 0.0178 0.67–0.74 0.0001 0.0012 0.0007
(N=1503) 3 - FI-CD 0.7279 0.0175 0.69–0.76
4 - FI-CGA 0.7237 0.0176 0.69–0.76
1 – MPI 0.7492 0.0163 0.72–0.78
CIRS$3 2 – FI-SOF 0.6814 0.0173 0.65–0.71 ,0.0001 ,0.0001 0.0002
(N=1257) 3 - FI-CD 0.7202 0.0167 0.69–0.75
4 - FI-CGA 0.7197 0.0170 0.69–0.75
1 – MPI 0.7374 0.0218 0.69–0.78
MNA,17 2 – FI-SOF 0.6833 0.0234 0.64–0.73 0.0007 0.0651 0.0669
(N=534) 3 - FI-CD 0.7164 0.0221 0.67–0.76
4 - FI-CGA 0.7146 0.0224 0.67–0.76
1 – MPI 0.7069 0.0306 0.65–0.77
Number of drugs $7 2 – FI-SOF 0.6473 0.0321 0.58–0.71 0.0197 0.3952 0.0073
(N=463) 3 - FI-CD 0.6972 0.0313 0.63–0.76
4 - FI-CGA 0.6712 0.0317 0.61–0.73
AUC: areas under curve; SE: standard error; CI: confidence interval; ADL: activities of daily living; MPI: Multidimensional Prognostic Index; FI-SOF: Frailty Index derived
from the Study of Osteoporotic Fractures; FI-CD: Frailty Index based on cumulative deficits; FI-CGA: Frailty Index based on a Comprehensive Geriatric Assessment; IADL:
instrumental activities of daily living; SPMSQ: Short Portable Mental Status Questionnaire; CIRS: Cumulative Illness Rating Scale;
MNA: Mini Nutritional Assessment.
*AUCs were assessed by crude and adjusted logistic regression models, accounting for clustering due to centre effect.
doi:10.1371/journal.pone.0029090.t005
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suggested that they are mainly developed and validated as risk
assessment tools, and not as possible outcome measures [8]. At the
best of our knowledge, this was the first multicentre study that
compared four frailty indexes based on three conceptual
approaches in a population of older hospitalized patients. Some
studies made a comparison among these frailty instruments [9,11–
13,38–42], but in population-based settings [9,11–13,38,40] or in
home-care settings [39,42], considering hospitalized older patients
only for particular diagnostic categories (e.g., coronary artery
disease) [41]. In particular, a large population-based study made a
comparison among a functional domain model, a cumulative
deficit model, and a phenotypic model suggesting that different
theoretical constructs of frailty may capture different groups of
older adults, with some overlap [9]. Furthermore, the comparison
of two phenotypic frailty indexes suggested that the simple FI-SOF
based on three components and the more complex FI-CHS [1,13]
performed similarly in predicting falls, disability, fractures, and
mortality on both osteoporotic women [11] and men in the
Osteoporotic Fractures in Men Study [12]. In an hospital-based
setting, a study compared two phenotypic frailty indexes but only
in older patients with coronary artery disease [41]. Therefore, it is
becoming apparent a central role of the evaluation of frailty
indexes in hospital-based settings with high risk of mortality and in
which other than the acute phase care is important the choice of
the appropriate long-term treatment and management after the
hospital discharge.
This study has several strengths, including its large and
multicentre sample, its prospective design, comprehensive set of
measurements, and completeness of follow-up. Notwithstanding
these interesting findings, we must acknowledge that the present
study had some limitations. In fact, since the study population
included only patients admitted to geriatric units, a generalization
of the present findings also in other settings must be validated.
Furthermore, the other tested frailty instruments were originally
validated on different populations and settings [11,12,14–16], and
not in an hospital-based setting. However, we selected these tools
for the lack of instruments widely diffused and validated in this
setting, also considering the possibility of an application in the
clinical practice. On the other hand, also other studies conducted
in home-care [39,42] or hospital-based settings [41] made a
comparison among frailty instrument previously validated in other
settings. Finally, at present, differently from the other frailty
instruments selected for this study [11,12,14–16], we have no data
on the usefulness of the MPI in identifying older adults at high risk
of adverse outcomes traditionally linked to frailty such as falls or
institutionalization, although this instrument was based on
standardized assessment instruments widely employed in the
CGA. Indeed, the MPI is a valid and accurate predictor of all-
causes mortality in hospitalized older patients with acute diseases
or relapse of a chronic diseases [29–35]. In the present study, we
only evaluated the effectiveness of different tools in predicting
short- and long-term all-cause mortality risk in hospitalized older
patients, avoiding to study other outcomes traditionally linked to
frailty.
Conclusions
The present study suggests that a multidimensional and integral
conceptual model of frailty, taking into account not exclusively
physical problems in older people, but also psychological,
cognitive, and social components of frailty, and thus based on
the integral functioning of the individual, may have higher
predictive power for adverse outcomes and particularly all-cause
mortality in clinical settings. In the next future, it will be of interest
to consider also the causes of hospital admission and the diagnoses
at discharge, and to separate the causes of mortality when
evaluating accuracy and predictivity of different frailty instruments
in different settings.
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